Group 1: Business Overview - The company has 35 licensed operating projects nationwide, with the highest market share in first-tier cities [4] - The core competitive advantages of the biomass resource regeneration sector include project layout, full-chain industry advantages, and a focus on sustainable aviation fuel (SAF) supply [4] Group 2: Project Updates - The Beijing Tongzhou Organic Waste Resource Comprehensive Treatment Center project has a daily processing capacity of 2,100 tons and is expected to be operational in the second half of 2026 [4] - The company adheres to a "stable operation, ensure renewal" principle for expiring licensed projects, with plans for competitive bidding or negotiations for renewals [5] Group 3: Policy and Market Insights - The timeline for domestic aviation fuel mandatory blending policies is currently uncertain, but the company has advantages in UCO supply due to its early layout in major cities [6] - The company is cautiously exploring mergers and acquisitions, focusing on core business and industry chain extensions [7] Group 4: International Expansion - The company has established subsidiaries in Singapore and Hong Kong to expand overseas, focusing on regions rich in bioenergy resources [8] - Preliminary research has been conducted in Brazil and Malaysia for biomass resource regeneration, while overseas market expansion will be approached steadily due to potential operational risks [8]

Investment Rating - The report assigns a "Buy" rating to the company, indicating a positive outlook for its stock performance relative to the market index [3]. Core Views - The UCO market is characterized by a clear supply-demand logic, with long-term scarcity locked in by fundamentals. The theoretical potential for supply is significant, but actual utilization is limited due to collection and processing challenges [2]. - Demand for UCO is expected to grow significantly due to policy drivers, particularly in the EU, where SAF demand is projected to reach 264 million tons by 2030 and 825 million tons by 2035, translating to UCO demand of approximately 245 million tons and 766 million tons respectively [2]. - The company has reported record high earnings for the first three quarters of 2025, with revenue of 1.386 billion yuan and a net profit of 249 million yuan, reflecting a year-on-year increase of 0.17% and 28.89% respectively [2]. - The company is actively responding to changes in overseas policies and has implemented strategies to mitigate risks associated with EU anti-dumping investigations [2]. Summary by Sections Market Overview - The price of UCO has seen a slight increase, with the price range for UCO in China reaching 7,500-7,600 yuan per ton, up by approximately 50 yuan per ton week-on-week [1]. - The average spot price for UCO-based HVO recorded 2,642.55 USD per ton, reflecting a 1.90% increase [1]. Financial Performance - The company’s revenue projections for 2025-2027 are estimated at 1.932 billion, 2.222 billion, and 2.562 billion yuan respectively, with corresponding net profits of 289 million, 357 million, and 437 million yuan [6][7]. - The earnings per share (EPS) are projected to be 1.20, 1.48, and 1.81 yuan for the years 2025, 2026, and 2027 respectively [6][7]. Production Capacity - The company has a current raw material capacity of approximately 50,000 tons per year and is expected to enhance UCO production capacity through various projects in major cities [5]. - The Beijing Tongzhou project is anticipated to be operational by the second half of 2026, with a designed processing capacity of 2,100 tons per day [5].

Group 1 - The company holds a 2% stake in the Shenzhen Biomanufacturing Industry Innovation Center, which is the only national-level synthetic biology industry innovation center approved by the National Development and Reform Commission [2] - The company's core business focuses on two main areas: synthetic biological manufacturing and biomass resource regeneration, with synthetic biology being the strategic focus [2]

Core Viewpoint - The company reported a significant increase in net profit for Q3 2025, driven by strong demand and rising prices for its core product, waste cooking oil, which is a key raw material for sustainable aviation fuel (SAF) [2][3] Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of 1.386 billion yuan, a slight increase of 0.17% year-on-year; net profit attributable to shareholders was 249 million yuan, representing a year-on-year growth of 28.89% [1] - In Q3 alone, the net profit increased by 39.55% year-on-year, indicating a strong quarterly performance [2] - The company's operating cash flow remained robust, with a net amount of 367 million yuan for the first three quarters, up 5.80% year-on-year [2] Business Development - The company's biomass resource regeneration business is a core driver of its performance growth, benefiting from the upcoming mandatory blending ratio policy for SAF in Europe, which is expected to boost demand and prices for used cooking oil (UCO) [3] - The company has secured long-term stable rights for kitchen waste treatment through a BOT model, ensuring a low-cost supply of raw materials [3] - Currently, the company operates 35 biomass resource regeneration centers, with 21 already in operation, including five projects with a daily processing capacity of over 1,000 tons [3] Synthetic Biology Initiatives - The company is actively expanding into synthetic biology, with its human milk oligosaccharides (HMO) product entering the trial production phase [4] - The first phase of the HMO project involves 260 tons and is progressing smoothly, with key products receiving necessary approvals and certifications for market access [4] - The company has established connections with major target customers and is entering the qualification process for leading dairy enterprises, which is expected to generate revenue and profit starting next year [4] Revenue Forecast - The company is projected to achieve operating revenues of 1.901 billion, 2.363 billion, and 2.750 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 6.15%, 24.30%, and 16.38% [4] - Net profit attributable to shareholders is expected to be 300 million, 381 million, and 444 million yuan for the same years, with growth rates of 39.40%, 26.83%, and 16.48% [4] - Based on the closing price on October 24, 2025, the corresponding price-to-earnings ratios (PE) are projected to be 16.75, 13.20, and 11.34, with earnings per share (EPS) of 1.25, 1.58, and 1.84 yuan [4]